Astellas, a pharmaceutical company, announced yesterday that it has named Chelsea Glinski as its new national vice president, Oncology Sales, Astellas US.

In this role, Glinski will manage United States sales for the XTANDI brand, and contribute to the growth and development of the oncology sales organisation overall.

Glinski earlier served as executive director of Astellas' market access and reimbursement strategy, where she led the design and operations of reimbursement services and patient support programs across the Astellas portfolio. In addition, Glinski held operational roles in Astellas' Health Systems Business Unit. Prior to joining Astellas in 2012, Glinski served as a management consultant in the life sciences sector at Capgemini Consulting.